Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes.

Sundaramurthi H, Tonelotto V, Wynne K, O'Connell F, O'Reilly E, Costa-Garcia M, Kovácsházi C, Kittel A, Marcone S, Blanco A, Pallinger E, Hambalkó S, Piulats Rodriguez JM, Ferdinandy P, O'Sullivan J, Matallanas D, Jensen LD, Giricz Z, Kennedy BN

Open source

DOI: 10.12688/openreseurope.15973.2
Published: 2023
Container: Open research Europe
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.12688/openreseurope.15973.2,
  title = {Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes.},
  author = {Sundaramurthi H and Tonelotto V and Wynne K and O'Connell F and O'Reilly E and Costa-Garcia M and Kovácsházi C and Kittel A and Marcone S and Blanco A and Pallinger E and Hambalkó S and Piulats Rodriguez JM and Ferdinandy P and O'Sullivan J and Matallanas D and Jensen LD and Giricz Z and Kennedy BN},
  year = {2023},
  journal = {Open research Europe},
  doi = {10.12688/openreseurope.15973.2},
  url = {https://doi.org/10.12688/openreseurope.15973.2}
}

RIS

TY  - JOUR
TI  - Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes.
AU  - Sundaramurthi H
AU  - Tonelotto V
AU  - Wynne K
AU  - O'Connell F
AU  - O'Reilly E
AU  - Costa-Garcia M
AU  - Kovácsházi C
AU  - Kittel A
AU  - Marcone S
AU  - Blanco A
AU  - Pallinger E
AU  - Hambalkó S
AU  - Piulats Rodriguez JM
AU  - Ferdinandy P
AU  - O'Sullivan J
AU  - Matallanas D
AU  - Jensen LD
AU  - Giricz Z
AU  - Kennedy BN
PY  - 2023
JO  - Open research Europe
DO  - 10.12688/openreseurope.15973.2
UR  - https://doi.org/10.12688/openreseurope.15973.2
ER  -

APA

H, S., V, T., K, W., F, O., E, O., M, C., C, K., A, K., S, M., A, B., E, P., S, H., JM, P. R., P, F., J, O., D, M., LD, J., Z, G., & BN, K. (2023). Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes.. Open research Europe. https://doi.org/10.12688/openreseurope.15973.2

Source records

pubmed · retrieved 2026-09-25T16:53:33.080Z